apollo
logo
0Login
Introducing Our Latest Arrival!
Ultravist 0.623gm Infusion

Ultravist 0.623gm Infusion

Prescription drug
 Trailing icon
Consult Doctor

Manufacturer/Marketer

Zydus Cadila

Consume Type

PARENTERAL

Return Policy

Not Returnable

for this medicine

About Ultravist 0.623gm Infusion

Ultravist 0.623gm Infusion belongs to the class of diagnostic agents. It helps diagnose or find problems in the brain, heart, head, blood vessels, stomach, kidneys, ureters, bladder, and other body parts.

Ultravist 0.623gm Infusion contains Iopromide, an iodinated contrast agent. Contrast agents are used to create a clear picture of the different parts of the body during certain medical procedures, such as CT scans and angiography.

Experienced clinicians or trained individuals will administer Ultravist 0.623gm Infusion. Ultravist 0.623gm Infusion may cause certain side effects, such as injection site reactions, bleeding and pain, back pain, headache, dizziness, drowsiness, confusion, shortness of breath, urticaria, abnormal vision and altered taste.

Before taking the Ultravist 0.623gm Infusion, let your doctor know about all your medical conditions, sensitivities, and medications you are using. Also, inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding.

Uses of Ultravist 0.623gm Infusion

Used as a Diagnostic agent during certain medical procedures

Medicinal Benefits

Ultravist 0.623gm Infusion contains Iopromide as an active ingredient used during certain medical procedures. It is a radiopaque contrast medium that opacifies the vessels in the path of flow of the contrast medium, thereby visualizing the internal structures of the human body.

Directions for Use

A healthcare professional will administer Ultravist 0.623gm Infusion. Hence, do not self-administer. 

Storage

Store in a cool and dry place away from sunlight

Side Effects of Ultravist 0.623gm Infusion

  • Headache
  • Dizziness
  • Somnolence (drowsiness)
  • Confusion
  • Dyspnea (Shortness of breath)
  • Urticaria (Skin rash)
  • Urinary Retention
  • Abnormal Vision
  • Altered taste

Drug Warnings

Before taking the Ultravist 0.623gm Infusion, let your doctor know about all your medical conditions, sensitivities, and medications you are using. Before administration, inform your doctor if you have liver/kidney disease, cardiac disorders, bleeding disorders, diabetes, multiple myeloma or respiratory conditions. It is unknown whether Ultravist 0.623gm Infusion is safe for pregnant or nursing moms. As a result, notify your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. Ultravist 0.623gm Infusion is not intended for intrathecal use. Prolonged fasting and using a laxative before Ultravist 0.623gm Infusion is not recommended in the pediatric population. Caution should be exercised in patients with severely impaired renal function, combined renal and cardiac disease, combined renal and hepatic disease, severe thyrotoxicosis, myelomatosis, or anuria, especially when large doses are administered.

Drug Interactions

Drug-Drug Interactions: Ultravist 0.623gm Infusion may interact with medicines (e.g. acyclovir, adefovir, tenofovir), NSAIDs (e.g. bromfenac, diclofenac, naproxen) and antibiotics (e.g. neomycin, vancomycin).

Drug-Food Interactions: No interactions found.

Drug-Disease Interactions: Inform your doctor if you have myasthenia gravis (muscular weakness) before receiving Ultravist 0.623gm Infusion.

Drug-Drug Interactions Checker List

  • ACYCLOVIR
  • ADEFOVIR
  • TENOFOVIR
  • BROMFENAC
  • DICLOFENAC
  • NAPROXEN
  • NEOMYCIN
  • VANCOMYCIN

Habit Forming

No

Disease/Condition Glossary

Angiography: Angiography is a medical procedure that is used to visualize blood vessels in the body. It is primarily used to diagnose and evaluate conditions such as blockages or narrowing in the blood vessels. It is used for angiography procedures throughout the cardiovascular procedures including Cerebral and Peripheral Arteriography, Coronary Arteriography and Ventriculography, Pediatric Angiocardiography, Selective Visceral Arteriography and Aortography, Peripheral Venography (Phlebography), and Adult and Pediatric Intravenous Excretory Urography and Intravenous Adult and Pediatric Contrast Enhancement of Computed Tomographic (CECT) Head and Body Imaging.

bannner image

Alcohol

Caution

It is unknown whether Ultravist 0.623gm Infusion interacts with alcohol. However, as a precautionary measure, it is advisable not to take or limit alcohol.

bannner image

Pregnancy

Caution

Limited data is available on the effect of Ultravist 0.623gm Infusion in pregnancy. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Ultravist 0.623gm Infusion. Your doctor may prescribe this medicine if the benefits outweigh the risks.

bannner image

Breast Feeding

Caution

Let your doctor know if you are a nursing mother before taking Ultravist 0.623gm Infusion; your doctor may suggest stopping breastfeeding for a certain period.

bannner image

Driving

Caution

Do not drive or operate machines until you or alert after receiving Ultravist 0.623gm Infusion.

bannner image

Liver

Caution

If you have a pre-existing or a history of liver disease, inform your doctor before receiving Ultravist 0.623gm Infusion. Your doctor will weigh the benefits and potential risks before prescribing Ultravist 0.623gm Infusion.

bannner image

Kidney

Caution

If you have a pre-existing or a history of kidney disease, inform your doctor before receiving Ultravist 0.623gm Infusion. Your doctor will weigh the benefits and potential risks before prescribing Ultravist 0.623gm Infusion.

bannner image

Children

Safe if prescribed

Ultravist 0.623gm Infusion is safe for use in children if prescribed by the paediatrician. If administered, the child should be monitored carefully for any changes.

Country of origin

India
Other Info - UL11608

FAQs

Ultravist 0.623gm Infusion is used as a Diagnostic agent during certain medical procedures.
Ultravist 0.623gm Infusion contains Iopromide, which opacifies the vessels in the path of flow of the contrast medium, thereby visualising the internal structures of the human body.
No, Ultravist 0.623gm Infusion is not recommended for intrathecal route of administration. It may result in serious adverse effects such as convulsions, cerebral haemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, seizures, rhabdomyolysis, hyperthermia, brain oedema, and death.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.